Cargando…
Deciding Whether to Take Sacubitril/Valsartan: How Cardiologists and Patients Discuss Out‐of‐Pocket Costs
BACKGROUND: Out‐of‐pocket costs have significant implications for patients with heart failure and should ideally be incorporated into shared decision‐making for clinical care. High out‐of‐pocket cost is one potential reason for the slow uptake of newer guideline‐directed medical therapies for heart...
Autores principales: | Rao, Birju R., Akrobetu, Dennis J., Dickert, Neal W., Nguyen, Thuy‐Vi, Davis, J. Kelly, Campagna, Ada, Mitchell, Andrea R., Sharma, Anu, Speight, Candace D., Barks, Mary Carol, Farley, Samantha, Gutterman, Sophia, Santanam, Taruni, Ubel, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122884/ https://www.ncbi.nlm.nih.gov/pubmed/36974764 http://dx.doi.org/10.1161/JAHA.122.028278 |
Ejemplares similares
-
PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19
por: Thomson, Mary Catherine, et al.
Publicado: (2021) -
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure
por: Rao, Birju R., et al.
Publicado: (2022) -
Discussing Out‐of‐Pocket Costs With Patients: Shared Decision Making for Sacubitril‐Valsartan in Heart Failure
por: Smith, Graham H., et al.
Publicado: (2018) -
Framing Benefits in Decision Aids: Effects of Varying Contextualizing
Statements on Decisions About Sacubitril-Valsartan for Heart
Failure
por: Thomson, Mary C., et al.
Publicado: (2021) -
Show Me the Money: Patients’ Perspectives on a Decision Aid for Sacubitril/Valsartan Addressing Out-of-Pocket Cost
por: Dickert, Neal W., et al.
Publicado: (2020)